NEI is the preeminent provider of continuing education and practice-based tools for healthcare professionals who treat patients with mental health disorders.
Thousands of clinicians consider NEI their top mental health resource for point of care answers and continuing medical education (CME). Here's why:
NEI Prescribe, our prescribing app, features over 150 psychiatric medications and has a dedicated Child and Adolescent section with in-depth coverage of the most commonly prescribed psychotropic drugs in pediatric patients. Continuously updated and with an interactive filter to search for medications based on key drug interactions and side effects, NEI Prescribe is your tool for point of care prescribing. Our two annual conferences—NEI Congress in the fall and NEI Synapse in the spring—fuse learning, quality, and entertainment into an educational experience that will empower you to provide the best possible care for your patients. We offer hundreds of online CME activities, including animations, case studies, self-assessments, and encore presentations from NEI's live events. The Master Psychopharmacology Program is an online assessment-based certificate program designed to help clinicians develop proficiency in the practice of psychopharmacology. Create a free NEI account at http://nei.global to take advantage of these resources. NEI Membership is required to access the full spectrum of resources, including the Master Psychopharmacology Program. Learn more at http://nei.global/mbroverview. Neuroscience Education Institute, An HMP Global Company
03/20/2026
How do you turn complex neuroscience into something clinicians can actually use? From dynamic visuals to real-world clinical insights, NEI’s approach to psychopharmacology more accessible through visual, practical education designed for real-world clinical decision-making.
Because understanding the brain should lead to better patient care.
hashtag hashtag
03/19/2026
What if depression treatment could be guided by biology, not just symptoms?
Emerging research in neuroinflammation and insulin resistance is reshaping how we understand mood disorders and opening the door to more targeted, effective care. Explore how immunometabolic insights may transform clinical trials and treatment strategies. Read more: https://nei.global/21140
Join Dr. Roger McIntyre at the 2026 NEI Spring Congress and learn how emerging biomarkers and biotypes are shaping more precise, effective care. Register today at https://nei.global/spring
Emerging research in neuroinflammation and insulin resistance is reshaping how we understand mood disorders and opening the door to more targeted, effective care.
03/17/2026
Celebrate Brain Awareness Week with NEI Patient Education Resources! 🧠
NEI Patient Education offers easy-to-understand resources that help clinicians explain complex neuroscience concepts in ways patients can visualize and understand.
This Depression Neurobiology Coloring Page highlights the brain regions linked to symptoms of depression, helping patients connect brain science to their mental health.
We're celebrating Brain Awareness Week (March 16-22)! 🧠 This global initiative promotes awareness of neuroscience research and the incredible science behind the brain. Discover insights from NEI on how our growing understanding of the brain continues to shape mental health care. Explore more:
This Brain Awareness Week, we invite you to explore NEI’s educational resources and join us in celebrating the science of the brain.
03/11/2026
Early psychosis is a critical window for long term outcomes. On today's episode of the NEI Podcast, Dr. Andy Cutler talks with Dr. Robert Cotes about reducing duration of untreated psychosis, measuring more than symptom improvement, and engaging young adults and families in coordinated specialty care.
Tune in for practical strategies to support lasting recovery.
In this episode, Dr. Andy Cutler talks with Dr. Robert Cotes about optimizing outcomes in early psychosis and why the first episode is a critical window for intervention. T
03/03/2026
When depressive symptoms improve but the patient still feels no joy, what is the next step? In this free NEI Encore Presentation, Drs. Roger McIntyre and Andrew Cutler explore the neurobiology of anhedonia, why traditional antidepressants may fall short, and emerging pharmacologic and nonpharmacologic strategies to improve patient outcomes. Watch now and earn CME or CE credit:
In this free NEI Encore Presentation, Drs. McIntyre and Cutler review the brain circuits and neurotransmitters involved, the impact on prognosis and suicidality, and practical evidence based treatment strategies you can apply in practice.
02/28/2026
It’s Saturday Morning ☀️☕️ Spend it with Drs. Christoph Correll and Andrew Cutler as they share updates on emerging treatments and evolving strategies in schizophrenia care.
Log in now ➡️ https://nei.global/26smlfeb28
Haven’t registered yet? There’s still time. Registration is free but required.
Join Drs. Christoph Correll and Andrew Cutler to learn about recent advances in the treatment of schizophrenia that bring promise of improved patient outcomes.
02/26/2026
Schizophrenia care is evolving, and your approach should evolve with it.
Join us for a free, half-day virtual program exploring the latest neurocircuitry insights and emerging treatment strategies designed to improve real-world patient outcomes.
In this episode, Dr. Andy Cutler talks with Dr. Lisa Harding about how to choose between IV ketamine and intranasal esketamine for patients with difficult-to-treat depression. Listen now
In this episode, Dr. Andy Cutler talks with Dr. Lisa Harding about how to choose between IV ketamine and intranasal esketamine for patients with difficult-to-treat depression.
02/24/2026
This Saturday Morning! Discover how emerging therapies and evolving neurocircuitry insights are transforming schizophrenia treatment. Join us for this free virtual program. Save your spot:
Join us for a free, half-day virtual program where we will explore how novel therapies and evolving neurocircuitry insights are driving new strategies to improve outcomes in schizophrenia.
02/21/2026
The U.S. Food and Drug Administration (FDA) has approved milsaperidone for the acute treatment of manic or mixed episodes associated with bipolar I disorder and for the treatment of schizophrenia in adults. Milsaperidone is a novel atypical antipsychotic and the major active metabolite of iloperidone. Read more:
The FDA has approved milsaperidone for the treatment of schizophrenia and acute bipolar I disorder (manic or mixed episodes) in adults.
Be the first to know and let us send you an email when Neuroscience Education Institute posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Contact The Practice
Send a message to Neuroscience Education Institute:
Thousands of clinicians consider NEI their top mental health resource for point of care answers and continuing medical education (CME). Here's why:
NEI Prescribe, our prescribing app, features over 140 psychiatric medications and has a dedicated Child and Adolescent section with in-depth coverage of the most commonly prescribed psychotropic drugs in pediatric patients. Continuously updated and with an interactive filter to search for medications based on key drug interactions and side effects, NEI Prescribe is your tool for point of care prescribing.
Our two annual conferences—NEI Congress in the fall and NEI Synapse in the spring—fuse learning, quality, and entertainment into an educational experience that will empower you to provide the best possible care for your patients.
We offer hundreds of online CME activities, including animations, case studies, self-assessments, and encore presentations from NEI's live events.
The Master Psychopharmacology Program is an online assessment-based certificate program designed to help clinicians develop proficiency in the practice of psychopharmacology.
Our activities can be accessed online or from the NEI Learn app—CME credits are automatically saved to your NEI transcript for a seamless CME learning experience.
Create a free NEI account at http://nei.global to take advantage of these resources. NEI Membership is required to access the full spectrum of resources, including the Master Psychopharmacology Program. Learn more at http://nei.global/mbroverview.